Keyphrases
Adult T-cell Leukemia
100%
Aggressive Variant
9%
Antitumor Immune Response
9%
Asymptomatic Carriers
36%
Asymptomatic Controls
9%
Cancer Immunotherapy
9%
Clinical Parameters
9%
Healthy Controls
9%
Healthy Volunteers
9%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
36%
Indoleamine 2,3-dioxygenase 1 (IDO1)
9%
Kynurenine
54%
Kynurenine Pathway
9%
Lymph Node
9%
Lymphoma Patients
36%
Microenvironment
9%
Microenvironmental Factors
9%
Multivariate Analysis
9%
No Significant Difference
9%
Prognostic Factors
9%
Prognostic Significance
100%
Tryptophan
63%
Tryptophan Catabolism
100%
Biochemistry, Genetics and Molecular Biology
Cancer Immunotherapy
9%
Enzyme
9%
Human T-Lymphotropic Virus 1
36%
Immune Response
9%
Indoleamine 2,3-dioxygenase
9%
Kynurenine
54%
Kynurenine Pathway
9%
Multivariate Analysis
9%
Normal Human
9%
T Cell
100%
Tryptophan
100%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
9%
Human T-Lymphotropic Virus 1
36%
Immunotherapy
9%
Indoleamine 2,3 Dioxygenase
9%
Kynurenine
63%
Malignant Neoplasm
9%
Normal Human
9%
T Cell Leukemia
100%
Tryptophan
100%
Immunology and Microbiology
Cancer Immunotherapy
9%
Human T-Lymphotropic Virus 1
36%
Immune Response
9%
Indoleamine 2,3-dioxygenase
9%
Lymph Node
9%
Normal Human
9%
T Cell
100%